212 related articles for article (PubMed ID: 32213122)
1. A role for keratins in supporting mitochondrial organization and function in skin keratinocytes.
Steen K; Chen D; Wang F; Majumdar R; Chen S; Kumar S; Lombard DB; Weigert R; Zieman AG; Parent CA; Coulombe PA
Mol Biol Cell; 2020 May; 31(11):1103-1111. PubMed ID: 32213122
[TBL] [Abstract][Full Text] [Related]
2. Altered keratinocyte differentiation is an early driver of keratin mutation-based palmoplantar keratoderma.
Zieman AG; Poll BG; Ma J; Coulombe PA
Hum Mol Genet; 2019 Jul; 28(13):2255-2270. PubMed ID: 31220272
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of pachyonychia congenita-associated palmoplantar keratoderma: new insights into skin epithelial homeostasis and avenues for treatment.
Zieman AG; Coulombe PA
Br J Dermatol; 2020 Mar; 182(3):564-573. PubMed ID: 31021398
[TBL] [Abstract][Full Text] [Related]
4. Two novel de novo mutations of KRT6A and KRT16 genes in two Chinese pachyonychia congenita pedigrees with fissured tongue or diffuse plantar keratoderma.
Du ZF; Xu CM; Zhao Y; Liu WT; Chen XL; Chen CY; Fang H; Ke HP; Zhang XN
Eur J Dermatol; 2012; 22(4):476-80. PubMed ID: 22668561
[TBL] [Abstract][Full Text] [Related]
5. Keratin 16-null mice develop palmoplantar keratoderma, a hallmark feature of pachyonychia congenita and related disorders.
Lessard JC; Coulombe PA
J Invest Dermatol; 2012 May; 132(5):1384-91. PubMed ID: 22336941
[TBL] [Abstract][Full Text] [Related]
6. Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16.
Spaunhurst KM; Hogendorf AM; Smith FJ; Lingala B; Schwartz ME; Cywinska-Bernas A; Zeman KJ; Tang JY
Br J Dermatol; 2012 Apr; 166(4):875-8. PubMed ID: 22098151
[TBL] [Abstract][Full Text] [Related]
7. A large mutational study in pachyonychia congenita.
Wilson NJ; Leachman SA; Hansen CD; McMullan AC; Milstone LM; Schwartz ME; McLean WH; Hull PR; Smith FJ
J Invest Dermatol; 2011 May; 131(5):1018-24. PubMed ID: 21326300
[TBL] [Abstract][Full Text] [Related]
8. The molecular genetic analysis of the expanding pachyonychia congenita case collection.
Wilson NJ; O'Toole EA; Milstone LM; Hansen CD; Shepherd AA; Al-Asadi E; Schwartz ME; McLean WH; Sprecher E; Smith FJ
Br J Dermatol; 2014 Aug; 171(2):343-55. PubMed ID: 24611874
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress and dysfunctional NRF2 underlie pachyonychia congenita phenotypes.
Kerns ML; Hakim JM; Lu RG; Guo Y; Berroth A; Kaspar RL; Coulombe PA
J Clin Invest; 2016 Jun; 126(6):2356-66. PubMed ID: 27183391
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in pachyonychia congenita-associated keratins increase susceptibility to tooth decay.
Duverger O; Carlson JC; Karacz CM; Schwartz ME; Cross MA; Marazita ML; Shaffer JR; Morasso MI
PLoS Genet; 2018 Jan; 14(1):e1007168. PubMed ID: 29357356
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling in pachyonychia congenita skin.
Cao YA; Hickerson RP; Seegmiller BL; Grapov D; Gross MM; Bessette MR; Phinney BS; Flores MA; Speaker TJ; Vermeulen A; Bravo AA; Bruckner AL; Milstone LM; Schwartz ME; Rice RH; Kaspar RL
J Dermatol Sci; 2015 Mar; 77(3):156-65. PubMed ID: 25656049
[TBL] [Abstract][Full Text] [Related]
12. Keratin 16 regulates innate immunity in response to epidermal barrier breach.
Lessard JC; Piña-Paz S; Rotty JD; Hickerson RP; Kaspar RL; Balmain A; Coulombe PA
Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19537-42. PubMed ID: 24218583
[TBL] [Abstract][Full Text] [Related]
13. Rhomboid family member 2 regulates cytoskeletal stress-associated Keratin 16.
Maruthappu T; Chikh A; Fell B; Delaney PJ; Brooke MA; Levet C; Moncada-Pazos A; Ishida-Yamamoto A; Blaydon D; Waseem A; Leigh IM; Freeman M; Kelsell DP
Nat Commun; 2017 Jan; 8():14174. PubMed ID: 28128203
[TBL] [Abstract][Full Text] [Related]
14. Aberrant heterodimerization of keratin 16 with keratin 6A in HaCaT keratinocytes results in diminished cellular migration.
Trost A; Desch P; Wally V; Haim M; Maier RH; Reitsamer HA; Hintner H; Bauer JW; Onder K
Mech Ageing Dev; 2010 May; 131(5):346-53. PubMed ID: 20403371
[TBL] [Abstract][Full Text] [Related]
15. Identification of clinically useful predictive genetic variants in pachyonychia congenita.
Samuelov L; Sarig O; Adir N; Pavlovsky M; Smith FJ; Schwartz J; Hansen CD; Sprecher E
Clin Exp Dermatol; 2021 Jul; 46(5):867-873. PubMed ID: 33486795
[TBL] [Abstract][Full Text] [Related]
16. Keratin 6a mutations lead to impaired mitochondrial quality control.
Lehmann SM; Leube RE; Schwarz N
Br J Dermatol; 2020 Mar; 182(3):636-647. PubMed ID: 31004504
[TBL] [Abstract][Full Text] [Related]
17. A new KRT16 mutation associated with a phenotype of pachyonychia congenita.
Paris F; Hurtado C; Azón A; Aguado L; Vizmanos JL
Exp Dermatol; 2013 Dec; 22(12):838-9. PubMed ID: 24118415
[TBL] [Abstract][Full Text] [Related]
18. Keratins K2 and K10 are essential for the epidermal integrity of plantar skin.
Fischer H; Langbein L; Reichelt J; Buchberger M; Tschachler E; Eckhart L
J Dermatol Sci; 2016 Jan; 81(1):10-6. PubMed ID: 26603179
[TBL] [Abstract][Full Text] [Related]
19. Generalized bullae in a young girl with KRT6A-related pachyonychia congenita.
Liu J; Zhong W; Yu B; Lin Z; Zheng Y; Hu X
Pediatr Dermatol; 2020 Sep; 37(5):974-976. PubMed ID: 32662074
[TBL] [Abstract][Full Text] [Related]
20. Revisiting pachyonychia congenita: a case-cohort study of 815 patients.
Samuelov L; Smith FJD; Hansen CD; Sprecher E
Br J Dermatol; 2020 Mar; 182(3):738-746. PubMed ID: 31823354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
